Skip to content

13F-HR filed by 5AM Venture Management, LLC

5AM Venture Management, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 19 holding rows worth $457,812,000.

Accession
0001104659-22-061252
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 19 entries on the cover page, a total value of $457,812,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $457,812,000 with VALUE read as thousands by filing date, 13F file number 028-19757. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PEAR THERAPEUTICS INC704723105COM18,631,771$94,090,000thousands by filing date
CINCOR PHARMA INC17240Y109COM4,337,646$76,082,000thousands by filing date
ENTRADA THERAPEUTICS INC COM29384C108Stock4,408,379$41,395,000thousands by filing date
VOR BIOPHARMA INC929033108COM6,361,723$38,425,000thousands by filing date
RALLYBIO CORP75120L100COM3,980,724$27,785,000thousands by filing date
ARVINAS INC04335A105COM400,000$26,920,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM3,831,474$21,763,000thousands by filing date
AKOUOS INC00973J101COM4,135,784$19,645,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock862,286$18,927,000thousands by filing date
IMPEL PHARMACEUTICALS INC45258K109CMN2,884,791$18,376,000thousands by filing date
IVERIC BIO INC46583P102COM1,027,874$17,299,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock1,398,066$15,644,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM4,535,919$13,789,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock390,555$7,214,000thousands by filing date
JANUX THERAPEUTICS INC47103J105COM446,266$6,399,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM711,412$5,328,000thousands by filing date
CABALETTA BIO INC12674W109COMMON STOCK2,064,263$4,190,000thousands by filing date
5 01 ACQUISITION CORP33836P105CMN365,126$3,596,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock1,134,511$945,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-061252this filing2022-05-16acceptance time not in the bulk data set